MTVA METAVIA INC Product Launches 8-K Filing 2024 - Clinical Trial Results NeuroBo Pharmaceuticals announced positive results from a Phase 1 clinical trial of DA-1726, showing safety and tolerability for treating obesity.Get access to all SEC 8-K filings of the METAVIA INC